Name: Passage Bio, Inc. (PASG) Balance Sheet
Creator: FinSpry

Passage Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Passage Bio, Inc. (PASG) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	37.57	114.29	34.60	315.77	304.82
Short-Term Investments	39.18	92.59	155.01	186.81	169.82
Cash & Short-Term Investments	76.76	114.29	189.61	315.77	304.82
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.84	0.92	0.93	7.57	10.96
Total Current Assets	78.82	117.96	197.04	325.07	317.18
Non-Current Assets
Property, Plant & Equipment (Net)	23.13	32.15	42.24	23.81	2.80
Other Non-Current Assets	0.46	3.18	4.27	6.20	8.03
Total Non-Current Assets	23.60	35.33	46.51	30.01	10.82
Total Assets	102.41	150.55	243.55	355.08	328.01
Current Liabilities
Accounts Payable	0.74	1.30	4.07	9.45	5.27
Short-Term Debt	3.69	0.00	0.00	0.00	0.00
Accrued Liabilities	2.30	3.03	2.57	19.39	15.37
Deferred Revenue	8.23	0.00	0.00	0.00	0.00
Other Current Liabilities	8.23	11.67	11.01	20.05	15.91
Total Current Liabilities	19.36	16.34	18.35	29.50	21.18
Non-Current Liabilities
Long-Term Debt	21.79	22.92	23.83	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	6.92	0.04
Total Non-Current Liabilities	21.79	22.92	23.83	6.92	2.12
Total Liabilities	41.15	39.26	42.18	36.42	23.29
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-659.24	-594.54	-492.41	-356.69	-170.91
Accumulated Other Comprehensive Income	0.01	-0.04	-0.97	-0.41	-0.01
Additional Paid-in Capital	720.48	705.79	694.73	675.35	475.62
Shares Outstanding	3.10	2.75	2.73	2.71	0.00
Total Stockholders' Equity	61.26	111.25	201.37	318.66	304.71
Total Liabilities & Equity	102.41	150.55	243.55	355.08	328.01